| EMT subtype influences epithelial plasticity and mode of cell migration NM Aiello, R Maddipati, RJ Norgard, D Balli, J Li, S Yuan, T Yamazoe, ... Developmental cell 45 (6), 681-695. e4, 2018 | 587 | 2018 |
| Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy J Li, KT Byrne, F Yan, T Yamazoe, Z Chen, T Baslan, LP Richman, JH Lin, ... Immunity 49 (1), 178-193. e7, 2018 | 571 | 2018 |
| Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer M Ruscetti, JP Morris, R Mezzadra, J Russell, J Leibold, PB Romesser, ... Cell 181 (2), 424-441. e21, 2020 | 252 | 2020 |
| Regulation of pH by carbonic anhydrase 9 mediates survival of pancreatic cancer cells with activated KRAS in response to hypoxia PC McDonald, SC Chafe, WS Brown, S Saberi, M Swayampakula, ... Gastroenterology 157 (3), 823-837, 2019 | 168 | 2019 |
| Tumor cell–intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2) N Markosyan, J Li, YH Sun, LP Richman, JH Lin, F Yan, L Quinones, ... The Journal of clinical investigation 129 (9), 3594-3609, 2019 | 136 | 2019 |
| Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade CA Natale, J Li, J Zhang, A Dahal, T Dentchev, BZ Stanger, TW Ridky elife 7, e31770, 2018 | 120 | 2018 |
| Epigenetic and transcriptional control of the epidermal growth factor receptor regulates the tumor immune microenvironment in pancreatic cancer J Li, S Yuan, RJ Norgard, F Yan, YH Sun, IK Kim, AJ Merrell, Y Sela, ... Cancer discovery 11 (3), 736-753, 2021 | 81 | 2021 |
| Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism S Shah, WJ Carriveau, J Li, SL Campbell, PK Kopinski, HW Lim, N Daurio, ... Oncotarget 7 (28), 43713, 2016 | 69 | 2016 |
| Overcoming adaptive resistance to KRAS and MEK inhibitors by co-targeting mTORC1/2 complexes in pancreatic cancer WS Brown, PC McDonald, O Nemirovsky, S Awrey, SC Chafe, ... Cell Reports Medicine 1 (8), 2020 | 65 | 2020 |
| Global regulation of the histone mark H3K36me2 underlies epithelial plasticity and metastatic progression S Yuan, R Natesan, FJ Sanchez-Rivera, J Li, NV Bhanu, T Yamazoe, ... Cancer discovery 10 (6), 854-871, 2020 | 57 | 2020 |
| Tumor cell–intrinsic USP22 suppresses antitumor immunity in pancreatic cancer J Li, S Yuan, RJ Norgard, F Yan, T Yamazoe, A Blanco, BZ Stanger Cancer immunology research 8 (3), 282-291, 2020 | 55 | 2020 |
| Pharmacologic activation of the G protein–coupled estrogen receptor inhibits pancreatic ductal adenocarcinoma CA Natale, J Li, JR Pitarresi, RJ Norgard, T Dentchev, BC Capell, ... Cellular and Molecular Gastroenterology and Hepatology 10 (4), 868-880. e1, 2020 | 45 | 2020 |
| How tumor cell dedifferentiation drives immune evasion and resistance to immunotherapy J Li, BZ Stanger Cancer research 80 (19), 4037-4041, 2020 | 42 | 2020 |
| Activation of p38α stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungs J Gui, F Zahedi, A Ortiz, C Cho, KV Katlinski, K Alicea-Torres, J Li, L Todd, ... Nature cancer 1 (6), 603-619, 2020 | 42 | 2020 |
| MYC Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma R Maddipati, RJ Norgard, T Baslan, KS Rathi, A Zhang, A Saeid, ... Cancer discovery 12 (2), 542-561, 2022 | 40 | 2022 |
| KAT6A and ENL form an epigenetic transcriptional control module to drive critical leukemogenic gene-expression programs F Yan, J Li, J Milosevic, R Petroni, S Liu, Z Shi, S Yuan, JM Reynaga, Y Qi, ... Cancer discovery 12 (3), 792-811, 2022 | 38 | 2022 |
| Cell cycle regulation meets tumor immunosuppression J Li, BZ Stanger Trends in Immunology 41 (10), 859-863, 2020 | 37 | 2020 |
| Calcium signaling induces a partial EMT RJ Norgard, JR Pitarresi, R Maddipati, NM Aiello‐Couzo, D Balli, J Li, ... EMBO reports 22 (9), e51872, 2021 | 36 | 2021 |
| PTHrP drives pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability JR Pitarresi, RJ Norgard, AM Chiarella, K Suzuki, B Bakir, V Sahu, J Li, ... Cancer discovery 11 (7), 1774-1791, 2021 | 36 | 2021 |
| cIAP1/2 antagonism eliminates MHC class I–negative tumors through T cell–dependent reprogramming of mononuclear phagocytes K Roehle, L Qiang, KS Ventre, D Heid, LR Ali, P Lenehan, M Heckler, ... Science translational medicine 13 (594), eabf5058, 2021 | 32 | 2021 |
Ben StangerUniversity of PennsylvaniaVerified email at upenn.edu
